Last Updated: October 3, 2025
Analyzing Management
Public company leadership plays a pivotal role in both initial due diligence and continual risk assessment for hedge funds and asset managers. ManagementTrack offers a consistent framework that eliminates distractions—highlighting distinct strengths and weaknesses, signaling potential red and green flags, and establishing a direct connection between CEO actions and investment performance.
CEO Bernard’s execution may not offset credibility issues from NeuMoDx, mixed record.
Analysis of QIAGEN CEO Thierry Bernard
While Thierry Bernard shows strong commercial execution, credibility issues from the NeuMoDx failure and a mixed macro record may challenge his ability to meet upgraded 2025 guidance.
Management evaluated Thierry Bernard’s track record and skillset against the following key factors for QGEN:
- Executing efficiency programs to achieve 2025 margin targets.
- Navigating China weakness and NIH budget cuts to protect sales.
- Sustaining QIAstat/QuantiFERON momentum to drive core growth.
- Offsetting discontinuation headwinds to meet upgraded 2025 guidance.
Thierry Bernard’s Track Record & Key Open Questions to Research
ManagementTrack provides track record analysis, career playbooks, strengths, and weaknesses for every CEO. It allows investors to dig deeper to uncover hard to find data to answer the most pressing questions.
Reach out to sales@paragonintel.com or visit https://paragonintel.com/access-now/ for more information.
Question #1
Given the pressure to meet new growth targets, how does Bernard balance pursuing transformative but high-risk strategic bets against the capital discipline required to avoid another costly failure like NeuMoDx?
Question #2
When Bernard has conviction in a strategic direction that faces strong opposition from key investors, does he prioritize building consensus or does he rely on his authority to push the decision through?
p>Question #3
When evaluating a new platform, does Bernard’s proven strength in operational execution and scaling cause him to underestimate the underlying strategic risks and long-term market viability?
Why Do Investors Use ManagementTrack?
What is ManagementTrack’s assessment of Thierry Bernard at QGEN?
ManagementTrack assesses Thierry Bernard by analyzing his career track record, core competencies, and potential weaknesses through its proprietary research and interviews with former colleagues. This profile is then evaluated against QGEN’s most critical challenges: executing efficiency programs to meet 2025 margin targets, navigating sales pressures from China and NIH budget cuts, sustaining momentum for core growth platforms like QIAstat and QuantiFERON, and offsetting product discontinuation headwinds to achieve upgraded guidance.
What additional methodologies does ManagementTrack utilize to link executive leadership with future company results?
ManagementTrack utilizes proprietary models to detect and quantify unusual instances of executive evasion during earnings call Q&A. The platform also performs a comprehensive analysis of all insider transactions to identify outlier trades that are predictive of future stock performance. These data points, integrated with the ManagementTrack Rating—a predictive 1-10 score for every executive—give investors a clear, forward-looking view on how an executive’s abilities will likely influence company results.
What is the scope of ManagementTrack’s executive coverage?
ManagementTrack provides real-time, comprehensive coverage of the C-suite for all publicly traded companies.
How to Learn More
Reach out to sales@paragonintel.com or visit https://paragonintel.com/access-now/ to see our deep dive analysis on any executive.
Author
Colby Howard is the co-founder and President of Paragon Intel. Paragon Intel’s ManagementTrack is the premier executive analysis platform for hedge funds, asset managers, corporations, boards, and recruiters. Our proprietary data, built over a decade of analysis, allows us to analyze each public company executive to understand their fit and ability to execute at their company. We leverage our proprietary data – key quantitative research on an executive’s career plus interviews with their former colleagues – with public documents, including SEC filings (10-K, 10-Q), investor presentations, press releases, and earnings call transcripts. to build a holistic, evidence-based view of an executive’s capabilities and playbook.
Sources
- Verified Career History by ManagementTrack for Thierry Bernard
- Analysis of Capital Allocation, Performance, and Fundamentals across career by ManagementTrack
- QIAGEN NV 10Q
- QIAGEN NV 10K
- QIAGEN NV Earnings Calls
- QIAGEN NV Press Releases
Relevant Links
- For more information on ManagementTrack’s Data visit: https://paragonintel.com/management-track-data/
- For more information on ManagementTrack’s Interview & Analysis visit: https://paragonintel.com/management-track-reports/
- For more information on ManagementTrack’s Interview library visit: https://paragonintel.com/management-track-report-library/
- For more information on ManagementTrack’s Evasion Analysis visit: https://paragonintel.com/earnings-call-evasion/
- For more information on how ManagementTrack helps hedge funds and asset managers visit: https://paragonintel.com/
